Elite Pharmaceuticals Inc (ELTP)

[namtae]

Will the CFO that previously jumped ship to a loser company make a correction on the call?

The Company has 79,008,661 total warrants to purchase shares of Common Stock outstanding with a weighted average exercise price of $0.1521 as of June 30, 2024 and March 31, 2024.

On April 28, 2017, the Company entered into an Exchange Agreement with Hakim, the Chairman of the Board, President, and Chief Executive Officer of the Company, pursuant to which the Company issued to Hakim 24.0344 shares of its Series J Preferred and warrants to purchase an aggregate of 79,008,661 shares of its Common Stock

So, it appears the CEO is the owner of these toxic warrants, not the Company.

Why does the SEC filing say the Company owns them?